Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 15, 2013, 02:30 ET
Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga® (regorafenib) tablets for the treatment of patients with...
More news about: Bayer HealthCare Pharmaceuticals Inc. , Bayer HealthCare LLC , Bayer AG
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |